New tuberculosis vaccines in India: Modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01(E) and BCG-revaccination

Mostrar otras versiones (1)

BACKGROUND: India had an estimated 2.9 million tuberculosis cases and 506 thousand deaths in 2021. Novel vaccines effective in adolescents and adults could reduce this burden. M72/AS01(E) and BCG-revaccination have recently completed Phase IIb trials and estimates of their population-level impact ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Clark, Rebecca A, Weerasuriya, Chathika K, Portnoy, Allison, Mukandavire, Christinah, Quaife, Matthew, Bakker, Roel, Scarponi, Danny, Harris, Rebecca C, Rade, Kirankumar, Mattoo, Sanjay Kumar, Tumu, Dheeraj, Menzies, Nicolas A, White, Richard G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980245/
https://www.ncbi.nlm.nih.gov/pubmed/36865172
http://dx.doi.org/10.1101/2023.02.24.23286406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980245/
https://www.ncbi.nlm.nih.gov/pubmed/36865172
http://dx.doi.org/10.1101/2023.02.24.23286406

Ejemplares similares